Laboratory animal allergy (LAA) is a significant occupational hazard for workers in a number of research settings, including the pharmaceutical industry.
Prevention of allergy and asthma is important because the illness can affect health and career.
In a major pharmaceutical company, in an effort to prevent LAA, a comprehensive program to reduce exposure to environmental allergens was developed.
The program included education, engineering controls, administrative controls, use of personal protective equipment, and medical surveillance.
A prospective survey of five years of data was completed to determine the effect of the program on the prevalence and incidence of LAA.
After instituting this program, we found that the prevalence ofLAA ranged from 12% - 22% and that the incidence was reduced to zero during the last two years of observation.
We conclude that LAA is preventable through the implementation of a comprehensive effort to reduce exposure to allergens.
Mots-clés Pascal : Animalerie, Exposition professionnelle, Médecine travail, Homme, Asthme, Allergie, Industrie pharmaceutique, Prévention, Epidémiologie, Etats Unis, Amérique du Nord, Amérique, Appareil respiratoire pathologie, Bronchopneumopathie obstructive, Immunopathologie
Mots-clés Pascal anglais : Laboratory animal facility, Occupational exposure, Occupational medicine, Human, Asthma, Allergy, Pharmaceutical industry, Prevention, Epidemiology, United States, North America, America, Respiratory disease, Obstructive pulmonary disease, Immunopathology
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0406542
Code Inist : 002B06C02. Création : 25/01/1999.